Clinical Management Guidelines for Tuberous Sclerosis Complex

This guide presents clinical management guidelines specifically for patients with a positive test result for TSC1 or TSC2 gene mutations. The guidelines are based on the Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations. It outlines various surveillance and management strategies for different aspects of Tuberous Sclerosis Complex (TSC), including brain, kidney, lung, skin, heart, and eye evaluations. The document emphasizes the importance of individualized treatment plans and the need for regular assessments, including imaging and screenings, based on the patient's age and clinical needs. It also discusses the potential risks associated with TSC2 mutations, including an increased chance of developing renal cancer and other non-cancerous tumors. Additionally, it highlights the significance of family testing for TSC2 mutations and the importance of patient education regarding the condition and its implications. Overall, the guide serves as a comprehensive resource for healthcare providers managing patients with TSC.